A nomogram for analyzing risk factors of poor treatment response in patients with autoimmune hepatitis.

Authors:
Wang X; Liu H; Wang P; Wang Y; Yi Y and 1 more

Journal:
Eur J Gastroenterol Hepatol

Publication Year: 2024

DOI:
10.1097/MEG.0000000000002661

PMCID:
PMC10695339

PMID:
37942733

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eur J Gastroenterol Hepatol

Abbreviation: Eur J Gastroenterol Hepatol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Gastroenterology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
AST to ALT ratio as a prospective risk predictor for liver cirrhosis in patients with chronic HBV i…
Lai X; Chen H; Dong X and 7 more (2024) - Transparency Score: 3/6
Construction and validation of the predictive model for gallbladder cancer liver metastasis patient…
Zhang W; Chen Z; Sa B. (2024) - Transparency Score: 3/6
Efficacy of vedolizumab during intravenous induction therapy in ulcerative colitis and Crohn's dise…
D'Haens G; Baert F; Danese S and 8 more (2024) - Transparency Score: 3/6
Management advice for patients with reflux-like symptoms: an evidence-based consensus.
Hungin AP; Yadlapati R; Anastasiou F and 8 more (2024) - Transparency Score: 3/6
Administration of maximum dose of mucolytic solution before upper endoscopy - a double-blind, rando…
Stepan M; Fojtík P; Psar R and 4 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest There are no conflicts of interest."

Evidence found in paper:

"This work was supported by the Natural Science Foundation of Beijing (7212053), Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202006), Dengfeng Talent Support Program of Beijing Municipal Administration of Hospitals (No.DFL20221601). This work was supported by the Natural Science Foundation of Beijing (7212053), Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine (ZYYCXTD-C-202006), Dengfeng Talent Support Program of Beijing Municipal Administration of Hospitals (No.DFL20221601)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025